KEY vs TERN
KeyCorp (KEY) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the KEY and TERN stock pages for the full models.
Not investment advice.